ArticleJournal of biomedical science2026

Smyca-FOXM1 ribonucleoprotein complex promotes homologous recombination and tumor immune evasion to define a therapeutic target of triple-negative breast cancer.

Han-Hsiun Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.